Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Critical limb ischemia.

David L Dawson1, Joseph L Mills

  • 1UC Davis Vascular Center, 4860 Y Street, ACC Building, Suite 3400, Sacramento, CA 95817, USA. david.dawson@ucdmc.ucdavis.ed

Current Treatment Options in Cardiovascular Medicine
|May 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endovascular-first revascularization is as safe and efficacious as open-first revascularization for acute limb ischemia.

Journal of vascular surgery·2026
Same author

Wound healing, wound-free period and amputation-free survival in patients with Wound, Ischemia, and foot Infection (WIfI) stage 3 and 4 disease.

Journal of vascular surgery·2026
Same author

Association of Depression With Inferior Amputation-Free Survival in Chronic Limb-Threatening Ischemia.

The Journal of surgical research·2026
Same author

Anatomically Directed Lower Extremity Gene Therapy for Ulcer Healing: A Double-Blind, Randomized, Placebo-Controlled Study (LEGenD-1).

Circulation. Cardiovascular interventions·2025
Same author

Two-Year Outcomes after Transcatheter Arterialization of the Deep Veins.

The New England journal of medicine·2025
Same author

Pedal Acceleration Time: A Novel Technique with Much Still to Be Discovered.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2025
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Critical limb ischemia (CLI), a severe form of peripheral artery disease (PAD), requires prompt treatment to prevent amputation. While endovascular therapies have advanced, surgical bypass may offer more durable results for select patients.

Area of Science:

  • Vascular Surgery
  • Endovascular Therapy
  • Peripheral Artery Disease

Background:

  • Critical limb ischemia (CLI) represents the most severe stage of peripheral artery disease (PAD).
  • CLI poses significant risks, including amputation and potentially fatal complications, if not diagnosed and treated promptly.
  • Advancements in endovascular therapies offer new options for lower-extremity arterial occlusive disease.

Purpose of the Study:

  • To compare the durability and outcomes of endovascular therapies versus surgical bypass for critical limb ischemia.
  • To identify patient subgroups who may benefit more from surgical intervention.
  • To outline indications for surgical treatment, including failures of endovascular procedures.

Main Methods:

  • Review of current endovascular CLI therapies.

Related Experiment Videos

  • Analysis of outcomes associated with surgical bypass for CLI.
  • Identification of factors influencing treatment choice (e.g., patient age, activity level, surgical risk).
  • Evaluation of reasons for endovascular therapy failure.

    • Main Results:

    • Endovascular therapies have expanded treatment options for long-segment arterial disease.
    • Surgical bypass may provide more durable results compared to endovascular interventions.
    • Younger, active, low-surgical-risk patients may achieve better outcomes with surgery.
    • Surgical intervention is crucial for managing failures of endovascular therapy, such as early technical issues or late occlusions.

    Conclusions:

    • Optimal management of CLI requires careful consideration of available revascularization options.
    • Surgical bypass remains a vital and potentially more durable option for specific CLI patient populations.
    • Endovascular therapy failures necessitate timely surgical evaluation and intervention.